Acuitas AMR Gene Panel

System, Nucleic Acid Amplification Test, Dna, Carbapenem Non-susceptible Gram Negative Organism, Colony

OpGen, Inc.

The following data is part of a premarket notification filed by Opgen, Inc. with the FDA for Acuitas Amr Gene Panel.

Pre-market Notification Details

Device IDK191288
510k NumberK191288
Device Name:Acuitas AMR Gene Panel
ClassificationSystem, Nucleic Acid Amplification Test, Dna, Carbapenem Non-susceptible Gram Negative Organism, Colony
Applicant OpGen, Inc. 9717 Key West Avenue Suite 100 Rockville,  MD  20850
ContactAutumn Collasius
CorrespondentRandy Prebula
Hogan Lovells, US LLP Columbia Square 555 Thirteenth Street, NW Washington,  DC  20004
Product CodePMY  
CFR Regulation Number866.1640 [🔎]
DecisionSubstantially Equivalent (SESE)
TypeTraditional
3rd Party ReviewedNo
Combination ProductNo
Date Received2019-05-13
Decision Date2021-09-30

NIH GUDID Devices

Device IdentifiersubmissionNumberSupplement
01812125010081 K191288 000
10812125010027 K191288 000
10812125010041 K191288 000
10812125010058 K191288 000
20812125010062 K191288 000
20812125010079 K191288 000
20812125010086 K191288 000
04260364751000 K191288 000
04260364751017 K191288 000
04260364751024 K191288 000
04260364751031 K191288 000
00812125010013 K191288 000
00812125010020 K191288 000
00812125010044 K191288 000
00812125010051 K191288 000
01812125010067 K191288 000
01812125010074 K191288 000
10812125010010 K191288 000

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.